✦ LIBER ✦

Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases

✍ Scribed by Shirley, Matt; McCormack, Paul L.

Book ID: 125386848
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 419 KB
Volume: 74
Category: Article
ISSN: 0012-6667
DOI: 10.1007/s40265-014-0198-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estimating the Economic Impact of Radium

Estimating the Economic Impact of Radium Ra 223 Dichloride (Radium-223) in Treatment of Castration-Resistant Prostate Cancer (CRPC) with Symptomatic Bone Metastases and No Known Visceral Metastatic Disease

✍ Valderrama, A.; Bilir, S.P.; Wehler, E.A.; Seal, B.S.; Wen, L.; Yaldo, A.; Munak 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

OC-0367 RADIUM-223 CHLORIDE AND IMPROVED

OC-0367 RADIUM-223 CHLORIDE AND IMPROVED SURVIVAL IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH BONE METASTASES

✍ V. Lewington; S. Boehmer; L. Franzén; R. Klijer; B. Mellado; R. Coleman; A. Cros 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Effect of radium-223 dichloride on sympt

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

✍ Sartor, Oliver; Coleman, Robert; Nilsson, Sten; Heinrich, Daniel; Helle, Svein I 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 527 KB

P124 Long-term safety of radium-223 dich

P124 Long-term safety of radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 ALSYMPCA study

✍ Nilsson, S; Schrader, A.J.; Kliment, J.; Solberg, A.; Franzén, L.; Bottomley, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

865 Effects of radium-223 dichloride (Ra

865 Effects of radium-223 dichloride (Ra-223) on total alkaline phosphatase (ALP) and prostate-specific antigen (PSA) in patients with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases from the phase 3 ALSYMPCA trial

✍ Heinrich, D.; Parker, C.; Shan, M.; Wilhelm, S.; Garcia-Vargas, J.; O'Bryan-Tear 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB

714 PAIN AND QUALITY OF LIFE (QOL) ANALY

714 PAIN AND QUALITY OF LIFE (QOL) ANALYSES FROM THE PHASE 3 RANDOMIZED ALSYMPCA STUDY WITH RADIUM-223 DICHLORIDE (RA-223) IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS WITH BONE METASTASES

✍ Tomblyn, Michael; Nilsson, Sten; Vogelzang, Nicholas; Sartor, A. Oliver; Cislo, 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB